CHRNB4 Antibodies

Santa Cruz Biotechnology features a diverse variety of CHRNB4 monoclonal antibodies for various research applications. CHRNB4 Antibodies are optimized for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CHRNB4, or the cholinergic receptor nicotinic beta-4 subunit, is integral to the formation and function of nicotinic acetylcholine receptors, which facilitate neurotransmission in the central and peripheral nervous systems. CHRNB4 influences multiple physiological processes, including muscle contraction and cognitive functions, making it a key target for research in neurobiology and pharmacology. Research focused on CHRNB4 advances understanding of neurological disorders and supports development of therapeutic approaches. Scientists can utilize specific conjugates including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) for enhanced detection and visualization. Investigating CHRNB4 expression patterns helps reveal its distribution across different tissues and cell types. Understanding CHRNB4's role in synaptic transmission provides valuable insights into neural circuit function and behavior. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of cholinergic signaling pathways and their impact on human health.